Diamandis EP. Theranos phenomenon: promises and fallacies. Clin Chem Lab Med 2015;53:989–93.Google Scholar
Li M, Diamandis EP. Theranos phenomenon – Part 2. Clin Chem Lab Med 2015;53:1911–2.Google Scholar
Li M, Diamandis EP. Theranos promises a new era of preventive health care – but where’s the physician? Clin Biochem 2015;48:1027.Google Scholar
Ioannidis JP. Stealth research: is biomedical innovation happening outside the peer-reviewed literature? J Am Med Assoc 2015;313:663–4.Google Scholar
Diamandis EP, Li M. The side effects of translational omics: overtesting, overdiagnosis, overtreatment. Clin Chem Lab Med 2015;54:389–96.Google Scholar
Li M and Diamandis EP. Will Theranos perform a pilot study and publish their results? Can J Pathol (in press).Google Scholar
Carreyrou J. FDA inspectors call Theranos blood vial ‘uncleared medical device’. Wall St J (East Ed) (October 28, 2015). http://www.wsj.com/articles/fda-inspectors-call-theranos-blood-vial-uncleared-medical-device-1445967607.
Carreyrou J. Theranos lab practices pose risk to patienta helth, regulators say. Wall St J (East Ed) (January 27, 2016). http://www.wsj.com/articles/theranos-lab-practices-pose-risk-to-patient-health-regulators-say-1453933143.
Carreyrou J, Weaver C, Siconolfi M. Deficiencies found at Theranos lab. Wall St J (East Ed) (January 27, 2016). http://www.wsj.com/articles/problems-found-at-theranos-lab-1453684743.
Carreyrou J. Theranos stops drawing blood from patients at Capital BlueCross Pennsylvania Store. Wall St J (East Ed) (January 30, 2016). http://www.wsj.com/articles/theranos-stops-drawing-blood-from-patients-at-capital-bluecross-pennsylvania-store-1454093470.
About the article
Published Online: 2016-03-11
Published in Print: 2016-05-01
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.